List goals for this meeting (e.g., Set design priorities for FY19):
Review CMN progress
Further ANF discussion, if possible
HPP/Sharable Clinical Pathways
Review confluence, GitHub, and shared work products
Discussion topics
Item
Presenter
Notes
Diagnostic (DX) Accelerator Project
Keith
Summarizing meeting with FDA around Accelerator project
Need to align and make compatible the VA clinical BPM+ workflows with FDA and their respective workflows
Reviewing different data elements from the DX Accelerator Research Question v.1
Suggesting to start from this question document and identify the Analysis Normal Form “Topics”
Then associate known codes for each topics
Clinical Input Form - the way the clinician would expect to capture clinical information (e.g., enter blood pressure, eye color)
Designation vs concept - mental notion i.e. designation of what a clinician would like to see (eye color is RED) but there is an underlying concept that is consistent across all input form
ANF
Keith
Reviewing the meaning and understanding behind designation vs concept
What is the Topic of a clinical statement
Moving Forward Plan
Keith
Reviewing guidance for moving forward (vs. COVID-19 response plan)
BPM+ work needs to be aligned to this particular plan for both current and future Business Process Automation development
Development of BPMN / DMN
-
Source is compliant to OMG standard, but is xml based
Action items
Add action items to close the loop on open questions or discussion topics:
Walk through the DX Accelerator Research Question and create topics and associated codes for each relevant DX data element involving COVID-19 Penni Hernandez
Review the current In-Person Pre-Arrival topics and associated codes for the current version of the DMN table Linda Wedemeyer
Send a doodle poll to establish twice a week meeting cadence Andrew Sills